Table 2.

Patient characteristics and relationships between ERβ1 and clinicopathologic factors

Variables	ERβ1-Negative		ERβ1-Positive		r P
	No. of patients (n =56)	%	No. of patients (n = 26)	%
Age(years)					−0.036 0.749
≤48	28	50.00	14	53.85
>48	28	50.00	12	46.15
Tumor size(cm)					0.009 0.936
≤2	22	39.29	10	38.46
2–5	32	57.14	15	57.69
>5	2	3.57	1	3.85
Metastatic lymph nodes					−0.368 0.001*
Negative	15	26.79	17	65.38
Positive	41	73.21	9	34.62
AR					0.309 0.005*
Negative	48	85.71	15	57.69
Positive	8	14.29	11	42.31
ZEB1					−0.330 0.003*
Negative	19	33.93	18	69.23
Positive	37	66.07	8	30.77
E-cadherin					0.391 0.0001*
Negative	47	83.93	12	46.15
Positive	9	16.07	14	53.85

*P < 0.05